Abstract
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare and fatal condition, which usually affects elderly males. It presents in the skin with frequent involvement of the bone-marrow, peripheral blood and lymph nodes. It has a dismal prognosis, with most patients dying within one year. The diagnosis is frequently challenging, with a characteristic immunophenotype. The best modality of treatment remains to be defined. Generally, patients require acute leukaemialike induction chemotherapy regimen. Here we present a local case who transformed from essential thrombocythemia into BPDCN over a 20-year period with sudden leukemic picture, and interestingly without any typical skin lesions.
References
Pagano L, Valentini CG, Grammatico S, Pulsoni A. Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches. Br J Haematol. 2016;174(2):188-202. Available from: https://doi.org/10.1111/bjh.14146
Sapienza MR, Pileri A, Derenzini E, et al. Blastic plasmacytoid dendritic cell neoplasm: state of the art and prospects. Cancers. 2019;11(5):595. Available from: https://doi.org/10.3390/cancers11050595
Swerdlow S, Campo E, Harris NL, et al. Eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2017.
Facchetti F. Plasmacytoid dendritic cell neoplasms. In: Orazi A, Weiss LM, Foucar KA, Knowles DM, eds. Knowles neoplastic hematopathology. 3rd ed. Philadelphia PA: Lippincott Williams & Wilkins, 2013.
Feuillard J, Jacob MC, Valensi F, et al. Clinical and biologic features of CD4+ CD56+ malignancies. Blood. 2002;99(5):1556-63. Available from: https://doi.org/10.1182/blood.v99.5.1556
Garnache-Ottou F, Vidal C, Biichlé S, et al. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? Blood Adv. 2019;3(24):4238-51. Available from: https://doi.org/10.1182/bloodadvances.2019000647
Julia F, Petrella T, Beylot-Barry M, et al. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol. 2013;169(3):579-86. Available from: https://doi.org/10.1111/bjd.12412
Pagano L, Valentini CG, Pulsoni A, et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica. 2013;98(2):239. Available from: https://doi.org/10.3324/haematol.2012.072645
Rauh MJ, Rahman F, Good D, et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement:case series and literature review. Leuk Res. 2012;36(1):81-6. Available from: https://doi.org/10.1016/j.leukres.2011.07.033
Wang H, Cao J, Hong X. Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review. Acta haematol. 2012;127(2):124-7. Available from: https://doi.org/10.1159/000334703